Cargando…

Identification of CKS2 as a novel prognostic biomarker and potential therapeutic target for oral squamous cell carcinoma

BACKGROUND: The cyclin-dependent kinase subunit 2 (CKS2) is recognized to have a substantial impact on the pathogenesis and advancement of several malignant neoplasms. Nevertheless, its biological function and prognostic significance in oral squamous cell carcinoma (OSCC) have yet to be thoroughly i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Danqi, Cai, Hongshi, Liang, Jianfeng, Wang, Ziyi, Song, Fan, Jiang, Yaoqi, Tan, Rukeng, Hou, Jingsong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10583009/ https://www.ncbi.nlm.nih.gov/pubmed/37859732 http://dx.doi.org/10.21037/tcr-23-511

Ejemplares similares

Integrative Analysis of N6-Methyladenosine-Related Enhancer RNAs Identifies Distinct Prognosis and Tumor Immune Micro-Environment Patterns in Head and Neck Squamous Cell Carcinoma
por: Cai, Hongshi, et al.
Publicado: (2022)

METTL14 inhibits malignant progression of oral squamous cell carcinoma by targeting the autophagy-related gene RB1CC1 in an m6A-IGF2BP2-dependent manner
por: Liang, Jianfeng, et al.
Publicado: (2023)

FTO Sensitizes Oral Squamous Cell Carcinoma to Ferroptosis via Suppressing ACSL3 and GPX4
por: Wang, Ziyi, et al.
Publicado: (2023)

CKS2 and RMI2 are two prognostic biomarkers of lung adenocarcinoma
por: Xiao, Dayong, et al.
Publicado: (2020)

High Expression of Tomm34 and Its Correlations With Clinicopathology in Oral Squamous Cell Carcinoma
por: Cai, Min, et al.
Publicado: (2021)

The CKS1/CKS2 Proteostasis Axis Is Crucial to Maintain Hematopoietic Stem Cell Function
por: Grey, William, et al.
Publicado: (2023)

Identification of CKS1B as a prognostic indicator and a predictive marker for immunotherapy in pancreatic cancer
por: Li, Lincheng, et al.
Publicado: (2022)

CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
por: Wang, Zhi-wen, et al.
Publicado: (2022)

CKS1 expression in melanocytic nevi and melanoma
por: Brożyna, Anna A., et al.
Publicado: (2017)

The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability
por: Grey, William, et al.
Publicado: (2018)

N6-Methyladenosine Methyltransferase METTL14-Mediated Autophagy in Malignant Development of Oral Squamous Cell Carcinoma
por: Wang, Fang, et al.
Publicado: (2021)

The CDK Subunit CKS2 Counteracts CKS1 to Control Cyclin A/CDK2 Activity in Maintaining Replicative Fidelity and Neurodevelopment
por: Frontini, Mattia, et al.
Publicado: (2012)

Depletion of Cks1 and Cks2 expression compromises cell proliferation and enhance chemotherapy-induced apoptosis in HepG2 cells
por: LIN, LINGQING, et al.
Publicado: (2016)

Identification of CKS2 and RRM2 as potential markers of vitiligo using bioinformatics analysis
por: Miao, Yu, et al.
Publicado: (2022)

Development and Validation of Autophagy-Related Gene Signature and Nomogram for Predicting Survival in Oral Squamous Cell Carcinoma
por: Hou, Chen, et al.
Publicado: (2020)

Localization of SSeCKS in unmyelinated primary sensory neurons
por: Irmen, Christopher P, et al.
Publicado: (2008)

Retracted: CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
por: Markers, Disease
Publicado: (2023)

Identification of Candidate Biomarkers and Analysis of Prognostic Values in Oral Squamous Cell Carcinoma
por: Huang, Guang-zhao, et al.
Publicado: (2019)

High Expression of CKS2 Predicts Adverse Outcomes: A Potential Therapeutic Target for Glioma
por: Yu, Kai, et al.
Publicado: (2022)

CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry
por: Hu, Menglong, et al.
Publicado: (2021)

Cks1: Structure, Emerging Roles and Implications in Multiple Cancers
por: Khattar, Vinayak, et al.
Publicado: (2013)

Loss of cks1 homeostasis deregulates cell division cycle
por: Krishnan, Anand, et al.
Publicado: (2010)

DHA Attenuates Hypoxia/Reoxygenation Injury by Activating SSeCKS in Human Cerebrovascular Pericytes
por: Yu, Yanli, et al.
Publicado: (2019)

Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma
por: Yang, Zongcheng, et al.
Publicado: (2019)

Identification and Validation of PLOD2 as an Adverse Prognostic Biomarker for Oral Squamous Cell Carcinoma
por: Sun, Yawei, et al.
Publicado: (2021)

LDHA Promotes Oral Squamous Cell Carcinoma Progression Through Facilitating Glycolysis and Epithelial–Mesenchymal Transition
por: Cai, Hongshi, et al.
Publicado: (2019)

Identification of SEC61G as a Diagnostic and Prognostic Biomarker in Oral Squamous Cell Carcinoma
por: Zhang, Shi-Long, et al.
Publicado: (2023)

The expression of the ubiquitin ligase subunit Cks1 in human breast cancer
por: Slotky, Merav, et al.
Publicado: (2005)

Cks Overexpression Enhances Chemotherapeutic Efficacy by Overriding DNA Damage Checkpoints
por: del Rincón, Sonia V., et al.
Publicado: (2014)

Identification and validation of potential novel biomarkers for oral squamous cell carcinoma
por: Zhang, Mengxue, et al.
Publicado: (2021)

Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021)

Midkine as a prognostic biomarker in oral squamous cell carcinoma
por: Ota, K, et al.
Publicado: (2008)

Identification of a polyamine-related signature and six novel prognostic biomarkers in oral squamous cell carcinoma
por: Tang, Jiezhang, et al.
Publicado: (2023)

Cks1 Is Required for Tumor Cell Proliferation but Not Sufficient to Induce Hematopoietic Malignancies
por: Kratzat, Susanne, et al.
Publicado: (2012)

Expression of CKS2 in Hepatocellular Carcinoma: Correlation with Survival Outcomes and Immune Microenvironment
por: Zhi, Renhou, et al.
Publicado: (2023)

Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma
por: Liu, Maohua, et al.
Publicado: (2023)

HtrA3: a promising prognostic biomarker and therapeutic target for head and neck squamous cell carcinoma
por: Chen, Yan, et al.
Publicado: (2023)

Prognostic biomarkers and therapeutic targets in oral squamous cell carcinoma: a study based on cross-database analysis
por: Yang, Wanli, et al.
Publicado: (2021)

Glut-1 as a prognostic biomarker in oral squamous cell carcinoma
por: Harshani, Jyotsna M, et al.
Publicado: (2014)

Publisher Correction: Establishment of high-throughput screening HTRF assay for identification small molecule inhibitors of Skp2-Cks1
por: Hu, Kaizhao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uv39fktgqgi9qsui3uqn9onfg6